About Kisspeptin-10 - Hormone & Libido Peptide

Kisspeptin-10 acts as a master switch for your reproductive hormones by triggering the release of GnRH, which signals the body to produce LH and FSH. This helps naturally ramp up testosterone production, fertility, and libido without shutting down your own system like TRT can.

WHAT THE RESEARCH SHOWS

Kisspeptin-10 is a 10-amino acid peptide derived from the C-terminal cleavage of kisspeptin-54 (encoded by the KISS1 gene). Originally discovered as a tumor metastasis suppressor (called metastin), subsequent breakthrough research revealed that it is the master upstream gatekeeper of human reproduction and the endocrine system. It acts by binding directly to the GPR54 receptor (KISS1R) located on GnRH neurons in the hypothalamus.
Here is what the clinical and physiological research shows:
* Master Upstream Regulator of the HPG Axis:
* Before Kisspeptin was understood, GnRH was thought to be the top of the chain. Research proved that Kisspeptin neurons in the arcuate nucleus directly control the pulsatile release of Gonadotropin-Releasing Hormone (GnRH).
* It essentially acts as the biological ignition switch for the entire Hypothalamic-Pituitary-Gonadal (HPG) axis. * Stimulation of LH, FSH, and Endogenous Testosterone:
* In human clinical trials on healthy men and men with secondary hypogonadism, administration of Kisspeptin-10 triggered a rapid, potent pulse of Luteinizing Hormone (LH) often within 30 to 60 minutes followed by an increase in Follicle-Stimulating Hormone (FSH) and a downstream spike in endogenous serum testosterone.
* Unlike hCG, which acts directly on the testicles like synthetic LH, Kisspeptin acts in the brain to trigger your body's own natural hormonal release.
* Psychosexual & Libido Modulation (fMRI Studies):
* Landmark clinical studies out of Imperial College London evaluated Kisspeptin's effects on the human brain using functional MRI (fMRI).
* Researchers found that Kisspeptin administration selectively activated limbic and paralimbic brain structures associated with sexual arousal, romantic processing, and mood elevation, while reducing negative emotional processing (anxiety). Participants showed heightened penile tumescence and increased responsiveness to romantic and sexual stimuli.
* Safer Fertility Treatment in Women:
* In reproductive medicine, Kisspeptin has been successfully studied as an alternative trigger for egg maturation in IVF protocols. Because it triggers a natural, physiological surge of LH, it achieves successful oocyte maturation with a drastically reduced risk of Ovarian Hyperstimulation Syndrome (OHSS) compared to standard hCG triggers.
The Pharmacological Caveat (Tachyphylaxis): Kisspeptin-10 has a very short half-life (a matter of minutes).  More importantly, continuous or excessively frequent exposure causes rapid receptor desensitization (downregulation) of the GPR54 receptor. In studies, continuous infusions actually shut down LH release after an initial spike. For research purposes, it requires intermittent or pulsatile dosing to maintain responsiveness. The Bottom Line: Research establishes Kisspeptin-10 as a powerful upstream neuroendocrine tool for stimulating natural LH and testosterone, modulating central libido and sexual processing, and restoring reproductive signaling without completely bypassing the brain's natural feedback loops.

STUDIES - All links

• George et al. 2011 – Kisspeptin-10 in men (PMC)
• George et al. 2011 – JCEM
• George et al. 2011 – Pretoria repository (full text)
• Thompson et al. 2004 – Kisspeptin-10 in rats
• Jayasena/Dhillo 2011 – Sexual dimorphism, JCEM
• Imperial – Kisspeptin as an IVF trigger
• Imperial – Kisspeptin IVF news (12 babies)
• Imperial – Safer IVF in women with PCOS
• Abbara et al. 2015 – Kisspeptin-54 in women at high OHSS risk
• Islam thesis – Ovarian volume by trigger type (Imperial)
• Peptide-DB – Kisspeptin study list

Lyophilised powder